Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b

The recent development of direct-acting antiviral agents (DAAs) against hepatitis C virus (HCV) infection could lead to higher sustained virological response (SVR) rates, with shorter treatment durations and fewer adverse events compared with regimens that include interferon. However, a relatively s...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:World J Gastroenterol
Glavni autori: Kanda, Tatsuo, Nirei, Kazushige, Matsumoto, Naoki, Higuchi, Teruhisa, Nakamura, Hitomi, Yamagami, Hiroaki, Matsuoka, Shunichi, Moriyama, Mitsuhiko
Format: Artigo
Jezik:Inglês
Izdano: Baishideng Publishing Group Inc 2017
Teme:
Minireviews
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5739919/
https://ncbi.nlm.nih.gov/pubmed/29290649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v23.i46.8120
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items